Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Stock data | 2024 | Change |
---|---|---|
Price | $0.10725797488051572 | N/A |
Market Cap | $7.96M | N/A |
Shares Outstanding | 74.21M | N/A |
Employees | 0 | N/A |